Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial Among 1.3 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback